TickerFactsScreenerDevelopers

Propanc Biopharma, Inc. (PPCB) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$2.24M2012: -$11.59M2013: -$1.36M2014: -$761.2K2015: -$1.71M2016: -$6.90M2017: -$5.74M2018: -$3.96M2019: -$2.61M2020: -$3.49M2021: -$1.81M2022: -$1.99M2023: -$1.78M2024: -$1.54M2025: -$57.28M-$57.28M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$57.28M-3628.9%
2024-$1.54M+13.5%
2023-$1.78M+10.8%
2022-$1.99M-9.9%
2021-$1.81M+48.1%
2020-$3.49M-33.6%
2019-$2.61M+34.0%
2018-$3.96M+31.0%
2017-$5.74M+16.8%
2016-$6.90M-304.4%
2015-$1.71M-124.1%
2014-$761.2K+44.1%
2013-$1.36M+88.2%
2012-$11.59M-418.5%
2011-$2.24M—